Crimson BioPharm Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $400K

  • Investors
  • 3

Crimson BioPharm General Information

Description

Operator of a biotechnological company intended to develop oral treatments for glioblastoma. The company is currently operating in stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9 Bradford Terrace
  • Unit 6
  • Brookline, MA 02446
  • United States
+1 (617)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 9 Bradford Terrace
  • Unit 6
  • Brookline, MA 02446
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Crimson BioPharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 30-Apr-2024 $400K Completed Stealth
1. Seed Round 04-Oct-2019 Completed Stealth
To view Crimson BioPharm’s complete valuation and funding history, request access »

Crimson BioPharm Patents

Crimson BioPharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4367116-A1 Crystalline polymorphs of epidermal growth factor receptor inhibitor, and compositions and methods thereof Pending 07-Jul-2021
EP-4367116-A4 Crystalline polymorphs of epidermal growth factor receptor inhibitor, and compositions and methods thereof Pending 07-Jul-2021
US-20240239796-A1 Crystalline polymorphs of epidermal growth factor receptor inhibitor, and compositions and methods thereof Pending 07-Jul-2021
WO-2023283206-A1 Crystalline polymorphs of epidermal growth factor receptor inhibitor, and compositions and methods thereof Inactive 07-Jul-2021
AU-2022297453-A1 (1h-pyrrolo[2,3-b]pyridin-1-yl)pyrimidin-2-yl-amino-phenyl--acrylamide inhibitors of egfr for use in the treatment of brain tumors Inactive 22-Jun-2021 A61K31/506
To view Crimson BioPharm’s complete patent history, request access »

Crimson BioPharm Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
EQRx Corporation Minority
Third Rock Ventures Venture Capital Minority
To view Crimson BioPharm’s complete investors history, request access »

Crimson BioPharm FAQs

  • When was Crimson BioPharm founded?

    Crimson BioPharm was founded in 2018.

  • Where is Crimson BioPharm headquartered?

    Crimson BioPharm is headquartered in Brookline, MA.

  • What industry is Crimson BioPharm in?

    Crimson BioPharm’s primary industry is Pharmaceuticals.

  • Is Crimson BioPharm a private or public company?

    Crimson BioPharm is a Private company.

  • What is Crimson BioPharm’s current revenue?

    The current revenue for Crimson BioPharm is .

  • How much funding has Crimson BioPharm raised over time?

    Crimson BioPharm has raised $1M.

  • Who are Crimson BioPharm’s investors?

    National Institutes of Health, EQRx, and Third Rock Ventures have invested in Crimson BioPharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process